Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Addus HomeCare is in a strong financial position with a diversified portfolio of in-home care services catering to high-need populations. The company's recent acquisitions, including the 2024 purchase of Gentiva, have shown its ability to successfully integrate and grow through M&A. Although potential changes to Medicaid funding and labor constraints in certain segments may pose risks, ADUS has proven its resiliency and is well positioned to continue its growth trajectory in the home care industry.

Bears say

Addus HomeCare is currently facing a number of challenges, including lower than expected revenue and margins in the Personal Care segment due to weather and possible minimum wage increases without rate adjustments. Despite two recent acquisitions in Indiana, the company's financials are strained with high cash and debt balances, and a potential repeal of the 80/20 Medicaid Access Rule could negatively impact its revenue. Additionally, any reductions to Medicare reimbursement rates or challenges with the integration of a major acquisition could further hurt financial projections.

Addus HomeCare (ADUS) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 8 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $132.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $132.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.